118000 — Metacare Co Income Statement
0.000.00%
- KR₩57bn
- KR₩100bn
- KR₩20bn
- 18
- 43
- 15
- 12
Annual income statement for Metacare Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | R2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 26,896 | 18,613 | 19,098 | 17,257 | 20,208 |
Cost of Revenue | |||||
Gross Profit | 2,463 | 5,096 | 6,517 | 6,528 | 7,672 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 30,242 | 26,535 | 17,788 | 16,301 | 13,145 |
Operating Profit | -3,346 | -7,921 | 1,310 | 956 | 7,063 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 12,310 | 7,497 | -49,555 | -4,543 | 2,675 |
Provision for Income Taxes | |||||
Net Income After Taxes | 11,728 | 9,856 | -49,555 | -4,547 | 2,675 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 11,252 | 7,740 | -49,555 | -14,540 | 9,277 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 11,252 | 7,740 | -49,555 | -14,540 | 9,277 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 270 | 212 | -611 | 45.8 | -13.1 |
Dividends per Share |